This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2012 Oct;4(10):499-502.

doi: 10.4103/1947-2714.102001.

Phosphodiesterase-III Inhibitors Amrinone and Milrinone on Epilepsy and Cardiovascular Activities

Mohammad Asif¹

Affiliations

PMID: 23112975
PMCID: PMC3482785
DOI: 10.4103/1947-2714.102001

Phosphodiesterase-III Inhibitors Amrinone and Milrinone on Epilepsy and Cardiovascular Activities

Mohammad Asif. N Am J Med Sci. 2012 Oct.

. 2012 Oct;4(10):499-502.

doi: 10.4103/1947-2714.102001.

Author

Mohammad Asif¹

Affiliation

¹ Department of Pharmacy, GRD (PG) IMT, Dehradun, Uttarakhan, India E-mail: aasif321@gmail.com.

PMID: 23112975
PMCID: PMC3482785
DOI: 10.4103/1947-2714.102001

No abstract available

PubMed Disclaimer

Figures

Figure 1
Amirinone - R¹=NH₂, R²=H, and Milrinone - R¹=CN, R²=CH₃

See this image and copyright information in PMC

Similar articles

Effects of epinephrine and phosphodiesterase III inhibitors on bupivacaine-induced myocardial depression in guinea-pig papillary muscle.
Azuma M, Yamane M, Tachibana K, Morimoto Y, Kemmotsu O. Azuma M, et al. Br J Anaesth. 2003 Jan;90(1):66-71. Br J Anaesth. 2003. PMID: 12488382
Comparison of the effects of amrinone, milrinone and olprinone in reversing bupivacaine-induced cardiovascular depression.
Hirabayashi Y, Igarashi T, Saitoh K, Fukuda H, Suzuki H, Shimizu R. Hirabayashi Y, et al. Acta Anaesthesiol Scand. 2000 Oct;44(9):1128-33. doi: 10.1034/j.1399-6576.2000.440916.x. Acta Anaesthesiol Scand. 2000. PMID: 11028735
Interaction of L-arginine and phosphodiesterase inhibitors in vasodilation of the porcine internal mammary artery.
Wallace AW, Tom WL. Wallace AW, et al. Anesth Analg. 2000 Apr;90(4):840-6. doi: 10.1097/00000539-200004000-00012. Anesth Analg. 2000. PMID: 10735785
Pharmacology of bipyridine phosphodiesterase III inhibitors.
Honerjäger P, Nawrath H. Honerjäger P, et al. Eur J Anaesthesiol Suppl. 1992;5:7-14. Eur J Anaesthesiol Suppl. 1992. PMID: 1600969 Review.
Pharmacology of bipyridine phosphodiesterase III inhibitors.
Honerjäger P. Honerjäger P. Am Heart J. 1991 Jun;121(6 Pt 2):1939-44. doi: 10.1016/0002-8703(91)90828-6. Am Heart J. 1991. PMID: 1852089 Review.

See all similar articles

Cited by

A novel phosphodiesterase target as a therapeutic approach: inhibiting DEN-induced hepatocellular carcinoma progression.
Kumar A, Rajput DS, Gupta MK, Kumar V, Singh H, Mishra AK, Chopra S, Chopra H. Kumar A, et al. EXCLI J. 2025 Mar 7;24:407-429. doi: 10.17179/excli2024-7941. eCollection 2025. EXCLI J. 2025. PMID: 40166422 Free PMC article. Review.

References

1. Delgado-Escueta AV, Treiman DM, Walsh GO. The treatable epilepsies. N Engl J Med. 1983;308:1508–14. - PubMed
1. Greene RJ, Harris ND. Pathology and Therapeutics for Pharmacists-A Basis for Clinical Pharmacy Practice. 2nd ed. 2003. pp. 449–62.
1. Walker R, Clive E. Clinical Pharmacy and Therapeutics. 3rd ed. 2003. pp. 465–81.
1. Herfindal ET, Gourley DR. Textbook of Therapeutics, Drug and Disease Management. 6th ed. 2001. pp. 1005–33.
1. Shafiee A, Rastkari N, Sharifzadeh M. Anticonvulsant activities of new 1,4-dihydropyridine derivatives containing 4-nitroimidazolyl substituents. DARU J Pharm Sci. 2004;12:81–5.

LinkOut - more resources

Full Text Sources